K. Brinkman, J. Smeitink, J. Romijn, and P. Reiss, Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy, The Lancet, vol.354, issue.9184, pp.1112-1115, 1999.
DOI : 10.1016/S0140-6736(99)06102-4

M. Caron, M. Auclair, C. Vigouroux, M. Glorian, C. Forest et al., The HIV Protease Inhibitor Indinavir Impairs Sterol Regulatory Element-Binding Protein-1 Intranuclear Localization, Inhibits Preadipocyte Differentiation, and Induces Insulin Resistance, Diabetes, vol.50, issue.6, pp.1378-1388, 2001.
DOI : 10.2337/diabetes.50.6.1378

D. Bruera, N. Luna, D. David, L. Bergoglio, and J. Zamudio, Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy, AIDS, vol.17, issue.13, pp.1917-1923, 2003.
DOI : 10.1097/00002030-200309050-00010

M. Yin, J. Dobkin, and K. Brudney, Bone mass and mineral metabolism in HIV+ postmenopausal women, Osteoporosis International, vol.36, issue.11, pp.1345-1352, 2005.
DOI : 10.1007/s00198-005-1845-0

C. Cazanave, M. Dupon, and V. Lavignolle-aurillac, Reduced bone mineral density in HIV-infected patients: prevalence and associated factors, AIDS, vol.22, issue.3, pp.395-402, 2008.
DOI : 10.1097/QAD.0b013e3282f423dd
URL : https://hal.archives-ouvertes.fr/inserm-00186715

V. Triant, T. Brown, H. Lee, and S. Grinspoon, Non-HIV-Infected Patients in a Large U.S. Healthcare System, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.9, pp.3499-3504, 2008.
DOI : 10.1210/jc.2008-0828

J. Teichmann, E. Stephan, and U. Lange, Osteopenia in HIV-infected Women Prior to Highly Active Antiretroviral Therapy, Journal of Infection, vol.46, issue.4, pp.221-227, 2003.
DOI : 10.1053/jinf.2002.1109

G. Madeddu, A. Spanu, and P. Solinas, Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy, Q J Nucl Med Mol Imaging, vol.48, pp.39-48, 2004.

J. Curtis, B. Smith, and M. Weaver, Ethnic Variations in the Prevalence of Metabolic Bone Disease among HIV-Positive Patients with Lipodystrophy, AIDS Research and Human Retroviruses, vol.22, issue.2, pp.125-131, 2006.
DOI : 10.1089/aid.2006.22.125

M. Rodríguez, B. Daniels, S. Gunawardene, and G. Robbins, High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients, AIDS Research and Human Retroviruses, vol.25, issue.1, pp.9-14, 2009.
DOI : 10.1089/aid.2008.0183

D. Nolan and S. Mallal, Getting to the HAART of insulin resistance, AIDS, vol.15, issue.15, pp.2037-2041, 2001.
DOI : 10.1097/00002030-200110190-00018

S. Dolan, J. Kanter, and S. Grinspoon, Longitudinal Analysis of Bone Density in Human Immunodeficiency Virus-Infected Women, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.8, pp.2938-2945, 2006.
DOI : 10.1210/jc.2006-0127

E. Bonnet, C. Delpierre, and A. Sommet, Total Body Composition by DXA of 241 HIV-Negative Men and 162 HIV-Infected Men, Journal of Clinical Densitometry, vol.8, issue.3, pp.287-292, 2005.
DOI : 10.1385/JCD:8:3:287

J. Gallant, S. Staszewski, and A. Pozniak, Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>, JAMA, vol.292, issue.2, pp.191-201, 2004.
DOI : 10.1001/jama.292.2.191

C. Duvivier, S. Kolta, and L. Assoumou, ANRS 121 Hippocampe study group. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients, AIDS, vol.23, pp.817-824, 2009.

M. Borderi, D. Gibellini, and F. Vescini, Metabolic bone disease in HIV infection, AIDS, vol.23, issue.11, pp.1297-1310, 2009.
DOI : 10.1097/QAD.0b013e32832ce85a

T. Brown and R. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review, AIDS, vol.20, issue.17, pp.2165-2174, 2006.
DOI : 10.1097/QAD.0b013e32801022eb

C. Amiel, A. Ostertag, and L. Slama, BMD Is Reduced in HIV-Infected Men Irrespective of Treatment, Journal of Bone and Mineral Research, vol.86, issue.Suppl, pp.402-409, 2004.
DOI : 10.1359/JBMR.0301246

C. Delpierre, E. Bonnet, and F. Marion-latard, Impact of HIV Infection on Total Body Composition in Treatment???Naive Men Evaluated by Dual-Energy X-ray Absorptiometry Comparison of 90 Untreated HIV-Infected Men to 241 Controls, Journal of Clinical Densitometry, vol.10, issue.4, pp.376-380, 2007.
DOI : 10.1016/j.jocd.2007.07.006

I. Schiefke, A. Fach, and M. Wiedmann, Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection, World Journal of Gastroenterology, vol.11, issue.12, pp.1843-1847, 2005.
DOI : 10.3748/wjg.v11.i12.1843

T. Brown, G. Mccomsey, M. King, R. Qaqish, B. Bernstein et al., Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.51, issue.5, pp.554-561, 2009.
DOI : 10.1097/QAI.0b013e3181adce44

P. Tebas, W. Powde-rly, and S. Claxton, Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy, AIDS, vol.14, issue.4, pp.63-67, 2006.
DOI : 10.1097/00002030-200003100-00005

G. Mccomsey, D. Kitch, E. Daar, C. Tierney, N. Jahed et al., Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202, Journal of Infectious Diseases, vol.203, issue.12, pp.1791-1801, 2011.
DOI : 10.1093/infdis/jir188

I. Ofotokun, E. Mcintosh, and M. Weitzmann, HIV: Inflammation and Bone, Current HIV/AIDS Reports, vol.106, issue.12, pp.16-25
DOI : 10.1007/s11904-011-0099-z

S. Mora, N. Sala, D. Bricalli, G. Zuin, G. Chiumello et al., Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy, AIDS, vol.15, issue.14, pp.1823-1829, 2001.
DOI : 10.1097/00002030-200109280-00011

S. Mora, Relationship of Sex Hormones to Bone Geometric Properties and Mineral Density in Early Pubertal Girls: Use of Correlation Analyses, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.11, pp.1698-1703, 2004.
DOI : 10.1210/jc.2004-0698

E. Seminari, A. Castagna, and A. Soldarini, Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients, HIV Medicine, vol.19, issue.2, pp.145-150, 2005.
DOI : 10.1210/en.142.12.5050

G. Pan, Z. Yang, S. Ballinger, and J. Mcdonald, Pathogenesis of osteopenia/ osteoporosis induced by highly active antiretroviral therapy for AIDS

J. Fakruddin and J. Laurence, HIV Envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor ??B Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-??/RANKL Cross-talk, Journal of Biological Chemistry, vol.278, issue.48, pp.48251-48258, 2003.
DOI : 10.1074/jbc.M304676200

F. Elefteriou, J. Ahn, and S. Takeda, Leptin regulation of bone resorption by the sympathetic nervous system and CART, Nature, vol.15, issue.7032, pp.514-520, 2005.
DOI : 10.1016/S0092-8674(00)81865-6

V. Arama, C. Tiliscan, A. Streinu-cercel, F. Ion, R. Mihailescu et al., SLD-ART study group. Insulin resistance and adipokines serum levels in a Caucasian cohort of HIV-positive patients undergoing antiretroviral therapy: a cross-sectional study, BMC Endocrinol Disord, pp.13-1186, 2013.

A. Conesa-botella, E. Florence, L. Lynen, R. Colebunders, J. Menten et al., Decrease of vitamin D concentration in patients with HIV infection on a Non Nucleoside Reverse Transcriptase Inhibitor containing regimen, AIDS Research and Therapy, vol.7, issue.1, p.40, 2010.
DOI : 10.1186/1742-6405-7-40

M. Cozzolino, M. Vidal, M. Arcidiacono, P. Tebas, K. Yarasheski et al., HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D, AIDS, vol.17, issue.4, pp.513-520, 2003.
DOI : 10.1097/00002030-200303070-00006

A. Conesa-botella, C. Mathieu, and R. Colebunders, Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?, AIDS Research and Therapy, vol.6, issue.1, p.4, 2009.
DOI : 10.1186/1742-6405-6-4

T. Brown and G. Mccomsey, Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D, Antiviral Therapy, vol.15, issue.3, pp.425-429, 2010.
DOI : 10.3851/IMP1502

J. Pascussi, A. Robert, and M. Nguyen, Possible involvement of pregnane X receptor???enhanced CYP24 expression in drug-induced osteomalacia, Journal of Clinical Investigation, vol.115, issue.1, pp.177-186, 2005.
DOI : 10.1172/JCI21867
URL : https://hal.archives-ouvertes.fr/inserm-00086875

J. Silver, C. Yalcindag, A. Sela-brown, R. Kilav, and T. Naveh-many, Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate, Kidney International, vol.56, pp.2-7, 1999.
DOI : 10.1046/j.1523-1755.1999.07310.x

P. Piliero and A. Gianoukakis, Ritonavir-associated hyperparathyroidism, osteopenia and bone pain, AIDS, vol.16, issue.11, pp.1565-1566, 2002.
DOI : 10.1097/00002030-200207260-00019

J. Yee, J. Sutton, R. Shew, and L. Olansky, Parathyroid hormone stimulation of alkaline phosphatase activity in cultured neonatal mouse calvarial bone cells: Involvement of cyclic AMP and calcium, Journal of Cellular Physiology, vol.35, issue.2, pp.246-250, 1986.
DOI : 10.1002/jcp.1041280216

X. Yu and S. Chandrasekhar, Parathyroid hormone (PTH 1?34) regulation of rat osteocalcin gene transcription, Endocrinology, vol.138, pp.3085-3092, 1997.

C. Grunfeld, M. Pang, W. Doerrler, J. Shigenaga, P. Jensen et al., Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection, J Clin Endocrinol Metab, vol.74, pp.1045-1052, 1992.

J. Shlay, G. Bartsch, and G. Peng, Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.5, pp.506-517, 2007.
DOI : 10.1097/QAI.0b013e31804216cf

P. Mallon, J. Miller, D. Cooper, and A. Carr, Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy, AIDS, vol.17, issue.7, pp.971-979, 2003.
DOI : 10.1097/00002030-200305020-00005

M. Dubé, D. Qian, and H. Edmondson-melançon, Prospective, Intensive Study of Metabolic Changes Associated with 48 Weeks of Amprenavir???Based Antiretroviral Therapy, Clinical Infectious Diseases, vol.35, issue.4, pp.475-481, 2002.
DOI : 10.1086/341489